Literature DB >> 28476245

TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA.

H Li1, Y Xiao1, S Wang2, Y Li1, X Zhong3, W Situ1, E Xiao4, Z Zhang5.   

Abstract

AIM: To investigate whether time-resolved imaging with interleaved stochastic trajectories (TWIST)-volumetric interpolated breath-hold examination (VIBE) hepatic arterial phase imaging technique improves image quality in patients experiencing transient severe motion (TSM) during abdominal magnetic resonance imaging (MRI) with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA).
MATERIALS AND METHODS: This retrospective study compares TSM in MRI images from 28 patients with focal liver lesions imaged with gadopentetic acid (Gd-DTPA) and 28 patients with focal liver lesions imaged with Gd-EOB-DTPA. Images were taken during the precontrast phase, five hepatic arterial phases acquired with a single breath-hold, portal venous phase, and late dynamic phase.
RESULTS: There was a significant difference in the mean motion scores for the arterial phase in Gd-EOB-DTPA cohort before, and after, enhancement (p<0.001); however, there was no significant difference in the Gd-DTPA cohort for the same (p<0.05). The mean motion scores in the five hepatic arterial phases in the Gd-EOB-DTPA cohort after enhancement were significantly higher than that in the Gd-DTPA cohort (p<0.001). TSM occurred significantly more frequently in the Gd-EOB-DTPA cohort (64.2%) than in the Gd-DTPA cohort (3.5%, p<0.001). The highest motion score in Gd-EOB-DTPA cohort occurred during the fourth arterial phase, which was significantly higher than the other four arterial phases after enhancement (p<0.001). Moderate and severe TSM (motion score ≥3) occurred mainly in the mid and mid-late arterial phase. All patients with arterial phase images affected by TSM (motion scores ≥3) had at least one arterial phase image with TSM score <3, which was of adequate image quality for diagnostic purposes.
CONCLUSION: The TWIST-VIBE hepatic arterial phase imaging technique can be used to acquire arterial images at abdominal MRI with Gd-EOB-DTPA, and these images have adequate quality for diagnosis in patients who are affected by TSM.
Copyright © 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28476245     DOI: 10.1016/j.crad.2017.03.013

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.

Authors:  Marie-Luise Kromrey; Masatoshi Hori; Satoshi Goshima; Kazuto Kozaka; Tomoko Hyodo; Yuko Nakamura; Akihiro Nishie; Tsutomu Tamada; Tatsuya Shimizu; Akihiko Kanki; Utaroh Motosugi
Journal:  Eur Radiol       Date:  2019-07-23       Impact factor: 5.315

2.  Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?

Authors:  Yu-Dong Xiao; Cong Ma; Jun Liu; Hua-Bing Li; Shun-Ke Zhou; Zi-Shu Zhang
Journal:  Exp Ther Med       Date:  2018-01-17       Impact factor: 2.447

3.  CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?

Authors:  Leonhard Gruber; Vera Rainer; Michaela Plaikner; Christian Kremser; Werner Jaschke; Benjamin Henninger
Journal:  Eur Radiol       Date:  2017-12-20       Impact factor: 5.315

4.  Evaluation of late arterial acquisition and image quality after gadoxetate disodium injection using the CDT-VIBE sequence.

Authors:  Fen Liu; Feng Ma; Guanlan Zhou; Chongtu Yang; Bin Xiong
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

5.  Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.

Authors:  Yanfen Fan; Yixing Yu; Ximing Wang; Mengjie Hu; Chunhong Hu
Journal:  BMC Med Imaging       Date:  2021-06-15       Impact factor: 1.930

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.